ArticleCells2026

Targeting p53-Driven FOXM1 Suppresses Tumor Growth and Synergistically Sensitizes to Chemotherapy in Triple-Negative Breast Cancer Models.

Sayra Dilmac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.